drugset / Trial / NCT00144235

Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue

NCT00144235 ↗

Phase 3 Completed 412 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy and safety of Pharmaton? PHL 00749 in improving cognitive function and allevi ating mental and physical stress in healthy male and female subjects leading demanding lifestyles.

Timeline

Start
2005-03
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginseng G115 Unknown 40 mg Oral
Subject Paullinia cupana extract PC102 Unknown 75 mg Oral

Indications

No indication recorded.